Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative virus of the coronavirus disease 2019 (COVID-19) pandemic. To establish a safe and convenient assay system for studying entry inhibitors and neutralizing antibodies against SARS-CoV-2, we constructed a codon-optimized, ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jie, Gao, Qingzhu, He, Changlong, Huang, Ailong, Tang, Ni, Wang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2020
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366953/
https://www.ncbi.nlm.nih.gov/pubmed/32837985
http://dx.doi.org/10.1016/j.gendis.2020.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366953/
https://www.ncbi.nlm.nih.gov/pubmed/32837985
http://dx.doi.org/10.1016/j.gendis.2020.07.006

Ejemplares similares